Email updates

Keep up to date with the latest news and content from BMC Genomics and BioMed Central.

Open Access Highly Accessed Methodology article

Novel insights into RNAi off-target effects using C. elegans paralogs

Jean-François Rual1*, Niels Klitgord1 and Guillaume Achaz2

Author Affiliations

1 Center for Cancer Systems Biology (CCSB) and Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA

2 UMR7138 & Atelier de Bioinformatique, Université Pierre & Marie Curie, Paris, France

For all author emails, please log on.

BMC Genomics 2007, 8:106  doi:10.1186/1471-2164-8-106


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2164/8/106


Received:7 May 2006
Accepted:19 April 2007
Published:19 April 2007

© 2007 Rual et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

In the few years since its discovery, RNAi has turned into a very powerful tool for the study of gene function by allowing post-transcriptional gene silencing. The RNAi mechanism, which is based on the introduction of a double-stranded RNA (dsRNA) trigger whose sequence is similar to that of the targeted messenger RNA (mRNA), is subject to off-target cross-reaction.

Results

We use a novel strategy based on phenotypic analysis of paralogs and predict that, in Caenorhabditis elegans, off-target effects occur when an mRNA sequence shares more than 95% identity over 40 nucleotides with the dsRNA. Interestingly, our results suggest that the minimum length necessary of a high-similarity stretch between a dsRNA and its target in order to observe an efficient RNAi effect varies from 30 to 50 nucleotides rather than 22 nucleotides, which is the length of siRNAs in C. elegans.

Conclusion

Our predictive methods would improve the design of dsRNA and ultimately the use of RNAi as a therapeutic tool upon experimental verification.

Background

The discovery of RNA interference (RNAi) has been an important breakthrough in biology in the past years [1,2]. Although RNAi-related phenomena have been described for decades [3], it is only recently that the silencing mechanism has been understood at the molecular level [4]. In Caenorhabditis elegans, Fire and colleagues described RNAi as a sequence-specific gene-silencing event based on the introduction of a double-stranded RNA (dsRNA) template having sequence similarity with the targeted messenger RNA [5]. Since then, the RNAi pathway has been shown to be conserved in a wide variety of eukaryotic organisms [6].

The physiological functions of RNAi range from immune response by degradation of exogenous genetic material [7] to development by regulation of gene expression [8-10]. In recent years, RNAi has been extensively used as an experimental tool for the analysis of gene function [11,12]. As our understanding of the underlying molecular machinery improves, the potential use of RNAi for therapy is becoming more evident [13,14].

In the RNAi pathway, long dsRNAs or short hairpin RNAs are processed and digested into small interfering RNAs (siRNA; 21 to 23 nucleotides) by Dicer, an RNase III family member [10,15]. After incorporation of the siRNA in the RNA-induced silencing complex, the siRNA-protein complex degrades mRNAs having sequence complementarity to the siRNA [4]. Interestingly, the RNAi machinery has also been shown to mediate translational repression or induce chromatin modification [16].

Since interference is based on sequence recognition, targeting a gene by RNAi can give rise to the silencing of another gene with similar sequence [17]. This phenomenon is referred to as off-target effect or cross-reaction and can occur through mRNA degradation or through translational repression [4]. Although RNAi phenotypes are generally assumed to be due to the sole knock-down of the targeted gene, they can also be due to multi-gene silencing. Numerous genome-wide RNAi analyses have been performed, e.g., for C. elegans [11] and Drosophila melanogaster [12]. Due to the issue of cross-reaction, RNAi data should be filtered prior to their analysis. In addition, accurate knowledge of RNAi specificity is critical when considering the use of RNAi as a therapeutic technology [13,14]. In this context, it is crucial to know how much similarity is necessary to observe RNAi off-target cross-reaction.

To assess identity requirements for RNA interference in C. elegans, Parrish et al. [18] used a series of altered GFP coding regions with different degrees of similarity to the transgene target. They found effective interference with dsRNAs (~520 nucleotides long) that were 96% identical to the target sequence (193 nucleotides maximum uninterrupted identity), less effective interference with a trigger that was 88% identical (41 nucleotides maximum uninterrupted identity), and no interference with dsRNA triggers that were 78% identical to the target (23 nucleotides maximum uninterrupted identity). Different studies based on mRNA expression profile analysis led to contradictory conclusions regarding RNAi target specificity [19-21]. For C. elegans RNAi data, Fraser et al. [22] used 200 nt with 80% identity as a threshold. Interestingly, in silico examination of potential cross-reaction as a function of siRNA length led to the conclusion that target specificity and low probability of off-target effects were optimally balanced for siRNAs of 21 nucleotides [23]. Finally, for data repositories such as RNAiDB [24], tools have been developed for analysis and visualization of the RNAi data as well as their potential risk of "contamination". Although these experiments give some indication of the sequence identity requirement, the question of how much similarity over how much length is necessary to observe off-target cross-reaction remains open.

Results and discussion

Using the RNAi phenotypes of paralogous genes in C. elegans, we devised a strategy to estimate the minimum degree of similarity needed to observe off-target effects. Hereafter, any gene that exhibits any kind of RNAi phenotype will be further referred to as a "PH gene" without further consideration of the phenotypic details. Similarly, any gene that was targeted by one or more RNAi experiments and for which no phenotype is described will be defined as a "WT gene". We extracted all 540 pairs of strict duplicates (gene families with only two members) for which both copies were targeted by RNAi (see Additional file 1). These pairs can be sorted according to the phenotypic class of both members: 393 (0.73) "WT/WT" pairs consist of two WT genes, 38 (0.07) "PH/PH" pairs of two PH genes and the remaining 109 (0.20) "WT/PH" pairs have one WT member and one PH member.

Additional file 1. List of the 540 pairs of gene duplicates, their largest clones and their corresponding phenotypic classification

Format: PDF Size: 160KB Download file

This file can be viewed with: Adobe Acrobat ReaderOpen Data

In order to predict whether these duplicates exhibit off-target cross-reaction, we elaborated a model where all duplicates are subject to off-target cross-reaction. In this model:

a) The probability of occurrence of PH/PH duplicate pairs is the same as the probability of occurrence of PH genes within singletons (i.e., genes with no paralogs). The probability of a gene to be duplicated and further preserved being only very weakly correlated with the phenotypic class a gene (Rual and Achaz, unpublished data), therefore, if at least one copy of the pair inherits the phenotypic class of their ancestral gene, we expect this first assumption to be true.

b) Some PH genes are annotated as WT genes due to the important fraction of false negatives. Actually, the fraction of false negative in large-scale RNAi experiments can be as high as 0.5 but the fraction of false positive is extremely low. In our dataset, we estimate the fraction of false negatives to be 0.37 (Methods).

c) Both genes in a duplicate pair give rise to the same RNAi phenotype. This last assumption seems reasonable when off-target cross-reaction happens, since the targeting of one copy would also knock down the other copy.

Under such a model, we expect 0.12 of PH/PH pairs, 0.14 of WT/PH pairs and of 0.74 WT/WT pairs. We then computed the probability (using a multinomial cumulative likelihood framework) of the entire set of 540 duplicate pairs to fit our model. We observed that the fractions of WT/WT, WT/PH and PH/PH of the entire set of pairs do not fit our model (N = 540; observed frequencies: 0.73 WT/WT, 0.20 WT/PH and 0.07 PH/PH; expected frequencies: see above; P < 10-7). From this result, we concluded that not all duplicates exhibit off-target effects. This result is expected because only very similar duplicates should exhibit off-target cross-reaction.

Accordingly, we sorted the pairs using the degree of sequence similarity between the genes and the corresponding RNAi clones (see Methods for details). Since we did not want to assume a sequence length for off-target cross-reaction, we chose to estimate the percentage identity over several lengths, i.e., over 25, 50, 100, 200 or 300 nucleotides. Sixteen out of the 540 pairs had at least one of their genes longer than 5 kb and identity were not estimated because of memory consumption. For each selected length, we grouped the pairs according to their percentage identity. For each group, we counted the number of WT/WT, WT/PH and PH/PH pairs and estimated the corresponding likelihood of these observed counts to fit the model of complete off-target cross-reaction. The higher the likelihood, the higher the chance this group is sensitive to off-target effects. Results (Figure 1) show that only genes having high degree of sequence similarity with the RNAi clones, i.e., 100% over 25 nt, ≥94% over 50 nt, ≥89% over 100 nt, ≥84% over 200 nt and ≥81% over 300 nt, fit well with the model (i.e. P > 0.2 for high identities). This strongly suggests that off-target effects occur when the percentage identity exceeds these thresholds. As sequence identity decreases, the likelihood of the data to fit the model decreases as well, illustrating the weaker effect of off-target.

thumbnailFigure 1. Off-target effect predicted to occur with genes having high degree of sequence similarity with the RNAi clones. In this figure, we represent the probability that duplicate pairs can be subject to off-target cross-reaction as a function of the identity between their coding sequences and the sequences of each other's RNAi clones. The maximum percentage identity between the genes and the RNAi clones was calculated over various lengths: 25 nt, 50 nt, 100 nt, 200 nt and 300 nt. The probability is the likelihood that the data (number of WT/WT, WT/PH and PH/PH pairs) fit a model where all duplicates are subject to off-target cross-reaction (see text). From this, we predict that only pairs having high degree of sequence similarity with the RNAi clones (100% over 25 nt, ≥94% over 50 nt, ≥89% over 100 nt, ≥84% over 200 nt and ≥81% over 300 nt) exhibit off-target cross-reaction.

To better understand sequence recognition requirements of the RNAi machinery, we looked for the minimum length of high-similarity stretch between the dsRNA and its target necessary to observe efficient RNA interference. More precisely, we calculated the minimal length over which sequence similarity is necessary to have a high likelihood to observe off-target cross-reaction. This is not a trivial problem because pairs that are very similar to the RNAi clone over 25 nt are usually also very similar over 50 nt (and so on). Consequently, to address this question of minimal length, we selected pairs whose maximum percentage identity with the RNAi clones is above the threshold over 25 nt (100% over 25 nt) and, in the same time, below the threshold over 50 nt (<94% over 50 nt). If such pairs exhibit a high likelihood of off-target cross-reaction, it suggests that having 100% identity over 25 nt is sufficient to observe off-target effects. On the other hand, if this likelihood is low, it suggests that having 100% identity over 25 nt is not sufficient to observe off-target effects. Out of 17 such pairs, 14 are WT/WT, 3 are WT/PH and none are PH/PH. The corresponding likelihood is relatively low (P = 0.059), suggesting that these pairs may be not subject to off-target cross-reaction and that the minimum length may be more than 25 nt. To compute more precisely the minimum length on which a high identity is necessary to observe off-target cross-reaction, we applied the same strategy to compare 25 nt with 30 nt, 30 nt with 40 nt, etc. Results (Table 1) show that the data fit well the model (i.e. P > 0.3) for pairs with high identity on 40 nt only (not on 30 nt or on 50 nt). On the contrary, pairs with high identity on 25 nt only or on 60 nt only fit poorly the model (i.e. P ~ 0.05). Keeping in mind that our analysis is performed with limited amount of data, it suggests that dsRNA having sequence similarity over 30 to 50 nucleotides (~twice the size of siRNAs) are optimal to observe efficient off-target cross-reaction and, by extrapolation, RNAi in C. elegans.

Table 1. Estimation of the minimum length of sequence similarity required in order to observe off-target cross-reaction

It is important to distinguish between "the minimum length of the dsRNA" and "the minimum length of high-similarity stretch between the dsRNA and its target" necessary to observe an efficient RNAi effect. Our analysis studies the later one. Our results do not imply that, overall, 30–50 nt dsRNAs are the most efficient in an RNAi experiment. On the contrary, in C. elegans, long dsRNA molecules tend to be much more efficient than small dsRNA molecules for reasons not only related to the interaction with the target mRNA but also to the initiation of the systemic effect and amplification of the RNAi effect. Here our results suggest that a stretch of 30–50 nt of high similarity inside the dsRNA molecule is sufficient to observe an efficient RNAi. A systematic experimental analysis of the minimum length of the dsRNA molecule having a 30–50 nt stretch of high similarity with targeted gene would complement our study. Moreover, we would like to mention that our results are based on the assumption that only one stretch of high similarity is necessary to observe off-target reaction. Therefore, our method does not assess whether one or multiple stretches of high similarity are necessary.

Our estimated range is in agreement with the current molecular model of the RNAi machinery. Indeed, for each dsRNA molecule having one fragment of 22 nucleotides identity with the targeted mRNA, the chance to have an siRNA of exactly 22 nucleotides identity with the same mRNA after Dicer processing is one out of 22. However, for dsRNA molecule having one fragment of 44 nucleotides identity with the targeted mRNA, the chance to have an siRNA of exactly 22 nucleotides identity with the same mRNA after Dicer processing is 100%.

To date, in mammalian cells, a typical RNAi experiment is performed by using conventional 21-mer synthetic RNA duplexes. In addition to the limitation of using long dsRNA triggers that can induce the non-specific interferon response, the choice of 21-mer long dsRNAs as RNAi triggers was mainly guided by the observation that 21-mer siRNAs are key players in the RNAi machinery (i.e., product of the dsRNA digestion by Dicer and component of the active RISC complex) [4]. However, recent studies demonstrate that, in mammalian cells, synthetic RNA duplexes 25–30 nucleotides in length can be up to 100-fold more potent than corresponding conventional 21-mer siRNAs [25]. The enhanced efficiency is attributed to the fact that longer dsRNAs are substrates of Dicer (while 21-mer siRNAs are only the products of the digestion). Indeed, Dicer would directly link the production of siRNAs to their incorporation in the RISC complex [26]. Likewise, although siRNAs are ~22 nucleotides long in C. elegans, our results suggest that sequences with similarity to the target mRNA over a length of 30 to 50 nucleotides are more efficient for RNAi.

We would like to mention that we are aware that the counts we used here can be sometimes low (especially in Table 1). However, the trend seems clear enough that we think our results are meaningful. Corroborating our results with new data sets from other species will allow to explore whether the results we report here are a specificity of C. elegans or constitute a more general trend.

Finally, we think that our predictions are ripe for experimental verifications using directed experiments. For example, one can try to induce interference with a non-duplicated target gene with various sequences construction (a single stretch of a chosen length sharing a chosen similarity with the target) and consequently analyze the RNAi phenotype as well as the mRNA expression level, possibly by real-time RT-PCR.

Conclusion

Our analysis represents a novel approach to estimate the threshold of sequence identity susceptible to off-target cross-reaction in an RNAi assay (≥95% identity over 40 nucleotides in C. elegans). While enormous amounts of phenotypic data are being generated for many organisms using RNAi, this strategy allows flagging potential false positive in RNAi datasets. The RNAi data of genes (i.e., all genes, not only duplicates) having greater than 95% identity over 40 nucleotides with another genes should be interpreted cautiously and tagged as potential false positives. We propose that similar strategies and criteria should be applied for cautious interpretation of RNAi data from any organisms. It is noteworthy to mention that our approach may be extended to study additional features having impact on RNAi cross-reaction. Those features include, for example, positional effect of mismatches, effects of UTRs, thermodynamical stability, or prevalence/exclusion of certain nucleotides at different positions. In addition, a better understanding of the off-target effect phenomenon should allow a better application of RNAi as an experimental tool or as a therapeutic approach.

Methods

Genome sequence

For C. elegans genome sequence and related genome annotation, we used version WS112 available at WormBase [27]. There are 19,920 predicted protein encoding genes in this release. For genes with more than one splicing variant, we arbitrarily chose the 'a' variant.

Paralogy

To assign paralogy, we pre-selected potential paralogs using BLASTP of all translated coding sequences against themselves. All coding sequences having one or more blast hits (other than themselves) with an e-value smaller than 10-30 (9,166 for C. elegans) were retained, translated and were further aligned together with an end-gap-penalty free global alignment [28], using the BLOSUM62 matrix. Each alignment score was then turned into a z-score. This was done by using all other alignment scores involving one of the two genes as a reference distribution. From this distribution, we calculated the mean and the standard error and computed the z-score as (score-mean)/stderr. We then empirically chose a cut-off of z-score >= 10 to assign paralogy between two genes. This leads to 8,087 (41% of all genes) C. elegans paralogs (grouped in 1,547 families). Here, we decided to keep only the 675 families of two members to keep the situation as simple as possible. The complicated relationships that can happen in a three or more partners cross-reaction can then be ignored.

RNAi phenotypes

The C. elegans RNAi data [11,22,29-31] were retrieved from WormBase WS112 [27]. In addition, we used data available from [32]. All in all, out of the 19,920 predicted genes in C. elegans, 17,270 (86.7%) have been screened at least once in an RNAi assay out of which 2,543 (15%) gave rise to a detectable phenotype different from WT in at least one RNAi screen. Gene duplicates represent 42% (7,327 genes) of the set of genes that where targeted at least once by an RNAi experiment. Among singleton genes (i.e., genes with no paralogs) for which we have a phenotypic class, the fraction of PH genes is 19% (1,846 out of 9,943).

As previously described [11,31,32], the rate of false negatives in a single RNAi screen is around 50%, based on comparison of the RNAi results to the loss-of-function phenotypes caused by genetic mutations. Matching our RNAi data to the phenotypes described for 372 genetic mutants, we observed that the overall false negative rate falls to 37% when the union of all screens is considered. Using similar comparison analysis with genetic data, very low rates of false positives (less than 4%) were previously described [11,31,32] and were considered negligible in our study. Because the rate of false negatives in an RNAi assay is considerably higher than the rate of false positives, if a gene was described as PH in at least one RNAi assay, it will be considered PH for our purpose. In our analysis, both viable and lethal phenotypes were scored in an identical manner (PH genes).

Local identity between the gene sequences and the RNAi clone sequences

After analyzing the overlapping positions of the genes and the RNAi clones on the genomic sequence, we identified 540 pairs of strict paralogs (gene families with only two members) for which both copies were targeted by one or more RNAi clones (see Additional file 1). For the genes that were targeted by more than one clone, we took the longest RNAi clone. For each pair of paralogs, we can determine "gene a" and its corresponding "RNAI clone a" as well as "gene b" and its corresponding "RNAi clone b". We calculated percentage identities between the sequences of 1) "gene a" and "RNAi clone b" and 2) "gene b" and "RNAi clone a" over lengths of 25 nt, 30 nt, 40 nt, 50 nt, 60 nt, 100 nt, 200 nt and 300 nt. For each pair and for each length, we determined the maximum percentage identity that it is possible to score between the two sequences (being "gene a" sequence versus "RNAi clone b" sequence or "gene b" sequence versus "RNAi clone a" sequence) and keep the lowest (this being more conservative). To determine the maximum percentage identity, we constructed all subsequences of the selected length from one gene and align each of these subsequences with the RNAi clone sequence of the other paralog. We used global alignment with no penalty for end gaps. An identity score matrix (+1 for matches and -1 for mismatches) was used with gap opening -4 and gap extension -1. In this scoring system, gaps are relatively rare. For each alignment, identity was calculated as the number of matches over the selected length (gaps do not count). To handle memory consumption, we excluded 16 pairs where at least one gene was larger than 5 kb from the analysis, leaving 540 - 16 = 524 pairs for the analysis of identity percent. The program was developed in C and sources are available upon request.

A model of off-target cross-reaction

We elaborated a model in which a pair of duplicates systematically exhibits cross-reaction. The idea is to test whether this model fits well for pairs of duplicates where both copies have sequences very similar to the sequences of each other's RNAi clones. In this model, we make three important assumptions:

a) The probability that an ancestral gene that experienced a duplication event (and gave rise to a pair) was WT or PH is given by the frequency of WT and PH in singleton genes. We assume that at least one copy of the pair inherits the phenotypic class.

b) In the RNAi dataset, the rate of false negatives (genes scored as WT but which are PH) is 0.37. False positives are considered negligible (see above).

c) If one member of a pair has an RNAi phenotype (a PH gene), the other one systematically has a phenotype as well (due to off-target cross-reaction). Thus if there were no false negatives, we shall only see PH/PH or WT/WT pairs.

Based on this model, we can compute the expected frequencies of WT/WT, WT/PH and PH/PH pairs. To do so, we first compute the adjusted fraction of PH genes, after correction for the rate of false negatives, as 0.19/(1 - 0.37) = 0.30. Then, if we assume complete off-target cross-reaction, the fraction of real PH/PH pairs is also 0.30. It is to be noted that results were also obtained by considering fraction of real PH/PH pairs equal to 0.15 or 0.60 and that the conclusions of the analysis remain the same. Finally, since each PH gene of the pair has 0.37 chance to be considered negative in an RNAi assay, only (1 - 0.37) × (1 - 0.37) of the real PH/PH pairs will be scored so. This leads to an expected fraction of observed PH/PH pairs of (1 - 0.37) × (1 - 0.37) × 0.30 = 0.12. Similarly, we expect to observe 2 × (1 - 0.37) × 0.37 × 0.30 = 0.14 of WT/PH pairs and 1 - 0.12 - 0.14 = 0.74 of WT/WT pairs.

Likelihood probability

Using the expected frequencies of PH/PH, WT/PH and WT/WT pairs, we computed the multinomial probability of having the exact observed number of pairs in each phenotypic category.

<a onClick="popup('http://www.biomedcentral.com/1471-2164/8/106/mathml/M1','MathML',630,470);return false;" target="_blank" href="http://www.biomedcentral.com/1471-2164/8/106/mathml/M1">View MathML</a>

where N is the total number of observed pairs, Nphph is the number PH/PH pairs and Nwtph is the number WT/PH pairs. Expected frequencies were estimated using the above model of off-target cross-reaction. Because the total number of observation is not the same in all bins, we had to use cumulative probabilities. If off-target effect does not occur, we intuitively expect to observe more WT/PH pairs and less PH/PH pairs. Therefore, we chose to cumulate the probabilities in the following way:

<a onClick="popup('http://www.biomedcentral.com/1471-2164/8/106/mathml/M2','MathML',630,470);return false;" target="_blank" href="http://www.biomedcentral.com/1471-2164/8/106/mathml/M2">View MathML</a>

One should mention that this cumulative likelihood probability relates to a one-tail statistical test. In that respect, the cumulative probability P will be higher than 0.5 if the observed counts exceed the expectations. In our particular case, if one observes too many PH/PH pairs or too few WT/PH pairs, it will give rise to a high probability. This is illustrated in Figure 1, when pairs having a local identity score lower than 100% show a better likelihood probability (for 50 nt, 100 nt, 200 nt and 300 nt). Nevertheless, this does not affect the loss of fit for data with medium identities.

Authors' contributions

JFR and GA contributed equally to this work. The project was conceived and designed by JFR and GA. Computational analyses were performed by GA. RNAi data were collected from WormBase by NK. Analysis and overall interpretation of data were performed by JFR and GA. The manuscript was written by JFR and GA. All authors read and approved the final manuscript.

Acknowledgements

We thank the C. elegans Sequencing Consortium, the Sanger Center and the Genome Sequencing Center for the genome sequences of C. elegans; WormBase for making RNAi data available; M. Vidal for his support; D. Dupuy, E. P. C. Rocha, I. Gonçalves, M. Boccara, K. Venkatesan, M. Cusick and J. Ceron for critical reading of the manuscript and all the members of the Atelier de Bio-Informatique, the CCSB and of the Vidal lab for their scientific help and their friendly support. We would also like to thank the anonymous referees for suggestions on earlier versions of the manuscript. JFR and NK were supported by National Cancer Institute grant 7 R33 CA81658-02 awarded to M. Vidal. GA was funded by La Fondation Singer-Polignac.

References

  1. Hannon GJ, Rossi JJ: Unlocking the potential of the human genome with RNA interference.

    Nature 2004, 431(7006):371-378. PubMed Abstract | Publisher Full Text OpenURL

  2. Mello CC, Conte D Jr.: Revealing the world of RNA interference.

    Nature 2004, 431(7006):338-342. PubMed Abstract | Publisher Full Text OpenURL

  3. Wingard SA: Hosts and symptoms of ring spot, a virus disease of plants.

    J Agric Res 1928, 37:127-153. OpenURL

  4. Meister G, Tuschl T: Mechanisms of gene silencing by double-stranded RNA.

    Nature 2004, 431(7006):343-349. PubMed Abstract | Publisher Full Text OpenURL

  5. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

    Nature 1998, 391(6669):806-811. PubMed Abstract | Publisher Full Text OpenURL

  6. Hannon GJ: RNA interference.

    Nature 2002, 418(6894):244-251. PubMed Abstract | Publisher Full Text OpenURL

  7. Waterhouse PM, Wang MB, Lough T: Gene silencing as an adaptive defence against viruses.

    Nature 2001, 411(6839):834-842. PubMed Abstract | Publisher Full Text OpenURL

  8. Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, Baillie DL, Fire A, Ruvkun G, Mello CC: Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing.

    Cell 2001, 106(1):23-34. PubMed Abstract | Publisher Full Text OpenURL

  9. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD: A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA.

    Science 2001, 293(5531):834-838. PubMed Abstract | Publisher Full Text OpenURL

  10. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH: Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans.

    Genes Dev 2001, 15(20):2654-2659. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  11. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, Kanapin A, Le Bot N, Moreno S, Sohrmann M, Welchman DP, Zipperlen P, Ahringer J: Systematic functional analysis of the Caenorhabditis elegans genome using RNAi.

    Nature 2003, 421(6920):231-237. PubMed Abstract | Publisher Full Text OpenURL

  12. Boutros M, Kiger AA, Armknecht S, Kerr K, Hild M, Koch B, Haas SA, Consortium HF, Paro R, Perrimon N: Genome-wide RNAi analysis of growth and viability in Drosophila cells.

    Science 2004, 303(5659):832-835. PubMed Abstract | Publisher Full Text OpenURL

  13. Jacque JM, Triques K, Stevenson M: Modulation of HIV-1 replication by RNA interference.

    Nature 2002, 418(6896):435-438. PubMed Abstract | Publisher Full Text OpenURL

  14. Borkhardt A: Blocking oncogenes in malignant cells by RNA interference--new hope for a highly specific cancer treatment?

    Cancer Cell 2002, 2(3):167-168. PubMed Abstract | Publisher Full Text OpenURL

  15. Bernstein E, Caudy AA, Hammond SM, Hannon GJ: Role for a bidentate ribonuclease in the initiation step of RNA interference.

    Nature 2001, 409(6818):363-366. PubMed Abstract | Publisher Full Text OpenURL

  16. Volpe TA, Kidner C, Hall IM, Teng G, Grewal SI, Martienssen RA: Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi.

    Science 2002, 297(5588):1833-1837. PubMed Abstract | Publisher Full Text OpenURL

  17. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

    Nature 2001, 411(6836):494-498. PubMed Abstract | Publisher Full Text OpenURL

  18. Parrish S, Fleenor J, Xu S, Mello C, Fire A: Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference.

    Mol Cell 2000, 6(5):1077-1087. PubMed Abstract | Publisher Full Text OpenURL

  19. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC, Hughes CM, Shanmugam KS, Bhattacharjee A, Meyerson M, Collins FS: Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells.

    Proc Natl Acad Sci U S A 2004, 101(7):1892-1897. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  20. Chi JT, Chang HY, Wang NN, Chang DS, Dunphy N, Brown PO: Genomewide view of gene silencing by small interfering RNAs.

    Proc Natl Acad Sci U S A 2003, 100(11):6343-6346. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  21. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS: Expression profiling reveals off-target gene regulation by RNAi.

    Nat Biotechnol 2003, 21(6):635-637. PubMed Abstract | Publisher Full Text OpenURL

  22. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J: Functional genomic analysis of C. elegans chromosome I by systematic RNA interference.

    Nature 2000, 408(6810):325-330. PubMed Abstract | Publisher Full Text OpenURL

  23. Qiu S, Adema CM, Lane T: A computational study of off-target effects of RNA interference.

    Nucleic Acids Res 2005, 33(6):1834-1847. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  24. Gunsalus KC, Yueh WC, MacMenamin P, Piano F: RNAiDB and PhenoBlast: web tools for genome-wide phenotypic mapping projects.

    Nucleic Acids Res 2004, 32 Database issue:D406-10. Publisher Full Text OpenURL

  25. Kim DH, Behlke MA, Rose SD, Chang MS, Choi S, Rossi JJ: Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.

    Nat Biotechnol 2005, 23(2):222-226. PubMed Abstract | Publisher Full Text OpenURL

  26. Pham JW, Pellino JL, Lee YS, Carthew RW, Sontheimer EJ: A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila.

    Cell 2004, 117(1):83-94. PubMed Abstract | Publisher Full Text OpenURL

  27. Harris TW, Lee R, Schwarz E, Bradnam K, Lawson D, Chen W, Blasier D, Kenny E, Cunningham F, Kishore R, Chan J, Muller HM, Petcherski A, Thorisson G, Day A, Bieri T, Rogers A, Chen CK, Spieth J, Sternberg P, Durbin R, Stein LD: WormBase: a cross-species database for comparative genomics.

    Nucleic Acids Res 2003, 31(1):133-137. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  28. Needleman SB, Wunsch CD: A general method applicable to the search for similarities in the amino acid sequence of two proteins.

    J Mol Biol 1970, 48(3):443-453. PubMed Abstract | Publisher Full Text OpenURL

  29. Gonczy P, Echeverri C, Oegema K, Coulson A, Jones SJ, Copley RR, Duperon J, Oegema J, Brehm M, Cassin E, Hannak E, Kirkham M, Pichler S, Flohrs K, Goessen A, Leidel S, Alleaume AM, Martin C, Ozlu N, Bork P, Hyman AA: Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III.

    Nature 2000, 408(6810):331-336. PubMed Abstract | Publisher Full Text OpenURL

  30. Maeda I, Kohara Y, Yamamoto M, Sugimoto A: Large-scale analysis of gene function in Caenorhabditis elegans by high- throughput RNAi.

    Curr Biol 2001, 11(3):171-176. PubMed Abstract | Publisher Full Text OpenURL

  31. Simmer F, Moorman C, Van Der Linden AM, Kuijk E, Van Den Berghe PV, Kamath R, Fraser AG, Ahringer J, Plasterk RH: Genome-Wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions.

    PLoS Biol 2003, 1(1):E12. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  32. Rual JF, Ceron J, Koreth J, Hao T, Nicot AS, Hirozane-Kishikawa T, Vandenhaute J, Orkin SH, Hill DE, van den Heuvel S, Vidal M: Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library.

    Genome Res 2004, 14(10B):2162-2168. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL